Haleon plc (HLN)
NYSE: HLN · Real-Time Price · USD
10.30
-0.01 (-0.10%)
At close: Jan 29, 2026, 4:00 PM EST
10.30
0.00 (0.00%)
After-hours: Jan 29, 2026, 7:00 PM EST
Haleon Market Cap
Haleon has a market cap or net worth of $45.6 billion as of January 29, 2026. Its market cap has increased by 10.67% in one year.
Market Cap
45.60B
Enterprise Value
56.51B
1-Year Change
10.67%
Ranking
Category
Stock Price
$10.30
Market Cap Chart
Since July 18, 2022, Haleon's market cap has increased from $34.14B to $45.60B, an increase of 33.54%. That is a compound annual growth rate of 8.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 45.60B | 1.49% |
| Dec 31, 2025 | 44.93B | 5.03% |
| Dec 31, 2024 | 42.77B | 13.06% |
| Dec 29, 2023 | 37.83B | 3.87% |
| Dec 30, 2022 | 36.42B | 6.67% |
| Jul 18, 2022 | 34.14B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zoetis | 55.07B |
| Takeda Pharmaceutical Company | 52.94B |
| Teva Pharmaceutical Industries | 37.32B |
| United Therapeutics | 20.53B |
| Regencell Bioscience Holdings | 15.85B |
| Viatris | 15.11B |
| Neurocrine Biosciences | 13.35B |
| Elanco Animal Health | 12.23B |